Mirum Pharmaceuticals, Inc. MIRM Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s investment proceeds?
- Mirum Pharmaceuticals, Inc. (MIRM) reported investment proceeds of $33.89M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s investment proceeds changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s investment proceeds increased by 94.4% year-over-year, from $17.43M to $33.89M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s investment proceeds has grown at a -16.8% compound annual growth rate (CAGR), from $155.6M to $74.43M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.